Skip to Content

MD Anderson Events

Use of Vemerafenib in Metastatic Melanoma

Use of Vemerafenib in Metastatic Melanoma

  • Review common targeted therapy treatment of metastatic melanoma
  • Identify pathology findings that indicate a patient is a candidate for BRAF inhibitors
  • Identify patients characteristics that indicate use of BRAF inhibitors
  • State toxicities of BRAF inhibitors and associated nursing interventions
  • Discuss how BRAF is used in combinations therapies

Date: 3/25/13, 5am to 6am
Time: 3/25/13, 5am to 6am
Location: P10 Conference Room
Format: Training/Employee Development
CME: Contact Hours: 1.0
Speaker: Tina Dett, FNP
Contact: Cindy Murphy - 39297 -

Contact Us

Questions? Need help?
Want to request an appointment?

Call askMDAnderson